Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb - 53 Year Stock Price History | BMY

Historical daily share price chart and data for Bristol Myers Squibb since 1972 adjusted for splits and dividends. The latest closing stock price for Bristol Myers Squibb as of June 10, 2025 is 49.97.
  • The all-time high Bristol Myers Squibb stock closing price was 72.96 on December 02, 2022.
  • The Bristol Myers Squibb 52-week high stock price is 63.33, which is 26.7% above the current share price.
  • The Bristol Myers Squibb 52-week low stock price is 39.35, which is 21.3% below the current share price.
  • The average Bristol Myers Squibb stock price for the last 52 weeks is 52.24.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Bristol Myers Squibb Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 53.9512 55.5677 62.4333 44.1200 49.9700 -9.71%
2024 47.6684 49.1398 58.6499 38.1833 55.3426 15.81%
2023 57.5896 64.9856 67.5573 45.1534 47.7893 -26.14%
2022 64.7896 53.9742 72.9626 53.9742 64.7068 18.98%
2021 54.3034 52.3079 59.9663 46.7782 54.3841 2.88%
2020 50.7007 52.3159 55.6940 38.3242 52.8618 0.41%
2019 40.6504 41.5710 52.6462 34.7861 52.6462 27.74%
2018 45.3367 47.3391 53.6108 38.6611 41.2142 -12.90%
2017 44.0223 44.6887 50.4585 35.4271 47.3159 7.71%
2016 47.0497 49.4811 57.3110 37.0063 43.9295 -13.49%
2015 46.9633 42.9272 51.9132 41.8039 50.7803 19.26%
2014 37.0414 36.6754 43.9448 32.9185 42.5809 14.18%
2013 30.2389 22.2623 37.5224 22.2623 37.2928 69.96%
2012 22.0844 22.6614 24.0955 20.7439 21.9424 -3.80%
2011 18.4419 16.4208 22.8427 15.6207 22.8103 39.44%
2010 15.5702 15.2713 17.0571 13.5309 16.3590 8.74%
2009 12.5273 13.4574 15.2764 9.8676 15.0448 14.82%
2008 11.7664 13.9004 14.4058 9.5953 13.1024 -6.03%
2007 14.9364 13.4784 16.7351 13.3353 13.9429 4.79%
2006 11.9897 11.2223 13.3050 10.1161 13.3050 19.90%
2005 11.4954 11.7352 12.4969 10.1551 11.0968 -6.14%
2004 11.4037 13.0800 13.6549 10.2612 11.8228 -7.24%
2003 10.9637 10.2452 12.7458 9.0088 12.7458 29.14%
2002 12.7910 20.7903 20.9742 8.5568 9.8700 -52.40%
2001 22.4510 27.1572 27.1572 19.9239 20.7371 -26.16%
2000 21.9612 24.0762 28.0830 16.3203 28.0830 17.10%
1999 25.3342 24.0371 29.1203 21.3228 23.9828 -2.79%
1998 19.9226 17.2489 24.6708 16.3717 24.6708 43.03%
1997 13.7422 9.5641 17.7514 9.5641 17.2489 77.25%
1996 7.8819 7.0875 10.2596 6.7230 9.7314 36.90%
1995 5.6156 4.6691 7.1288 4.6491 7.1082 53.55%
1994 4.3241 4.3491 4.7852 3.8867 4.6291 6.47%
1993 4.2790 4.7638 4.7638 3.7666 4.3479 -9.22%
1992 5.0129 6.0666 6.1010 4.3621 4.7893 -21.05%
1991 5.3477 4.4339 6.0666 4.0845 6.0666 36.06%
1990 3.8418 3.6508 4.4664 3.2665 4.4589 24.31%
1989 3.1030 2.7280 3.6229 2.7049 3.5868 28.94%
1988 2.5537 2.5522 2.7970 2.2946 2.7818 14.36%
1987 2.7589 2.4154 3.1490 2.1330 2.4324 2.84%
1986 2.1038 1.7282 2.4723 1.5869 2.3653 35.83%
1985 1.5115 1.3049 1.7647 1.2667 1.7414 30.58%
1984 1.1576 1.0620 1.3336 1.0281 1.3336 28.17%
1983 0.9395 0.8004 1.1645 0.7526 1.0405 30.54%
1982 0.6958 0.6085 0.8682 0.5897 0.7971 31.21%
1981 0.5889 0.5634 0.6603 0.5095 0.6075 9.16%
1980 0.4439 0.3893 0.5675 0.3291 0.5565 40.53%
1979 0.3605 0.3658 0.4014 0.3278 0.3960 7.87%
1978 0.3384 0.3305 0.3977 0.2797 0.3671 10.24%
1977 0.3161 0.3256 0.3499 0.2790 0.3330 1.34%
1976 0.3448 0.3236 0.3913 0.2944 0.3286 2.08%
1975 0.2859 0.2329 0.3419 0.2147 0.3219 41.00%
1974 0.2071 0.2059 0.2491 0.1429 0.2283 11.80%
1973 0.2649 0.2935 0.3059 0.1924 0.2042 -30.94%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $99.719B $48.300B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $226.424B 16.90
Amgen (AMGN) United States $155.924B 13.97
Gilead Sciences (GILD) United States $140.564B 14.60
Vertex Pharmaceuticals (VRTX) United States $114.570B 0.00
GSK (GSK) United Kingdom $83.746B 10.02
CSL (CSLLY) Australia $76.835B 0.00
Regeneron Pharmaceuticals (REGN) United States $55.883B 13.56
Alnylam Pharmaceuticals (ALNY) United States $39.638B 0.00
Argenex SE (ARGX) Netherlands $35.636B 97.27
BioNTech SE (BNTX) Germany $26.196B 0.00
Biogen (BIIB) United States $19.657B 8.48
Royalty Pharma (RPRX) United States $18.773B 7.93
Genmab (GNMSF) Denmark $14.413B 14.74
Genmab (GMAB) Denmark $14.267B 16.01
Incyte (INCY) United States $13.529B 102.78
Illumina (ILMN) United States $13.452B 25.52
Insmed (INSM) United States $12.874B 0.00
Exelixis (EXEL) United States $11.705B 19.87
Swedish Orphan Biovitrum (BIOVF) Sweden $11.389B 29.08
BioMarin Pharmaceutical (BMRN) United States $10.908B 17.72
Moderna (MRNA) United States $10.883B 0.00
Ascendis Pharma (ASND) Denmark $10.578B 0.00
Exact Sciences (EXAS) United States $10.305B 0.00
QIAGEN (QGEN) Netherlands $10.263B 19.97
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $8.328B 0.00
Blueprint Medicines (BPMC) United States $8.265B 0.00
Bio-Techne Corp (TECH) United States $7.820B 29.17
Revolution Medicines (RVMD) United States $7.559B 0.00
Roivant Sciences (ROIV) United Kingdom $7.532B 0.00
Repligen (RGEN) United States $7.398B 82.82
Verona Pharma American Depositary Share (VRNA) United Kingdom $7.206B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Jazz Pharmaceuticals (JAZZ) Ireland $6.769B 6.65
Halozyme Therapeutics (HALO) United States $6.701B 12.82
Legend Biotech (LEGN) United States $6.391B 0.00
TG Therapeutics (TGTX) United States $6.325B 166.00
Guardant Health (GH) United States $6.136B 0.00
Telix Pharmaceuticals (TLX) Australia $5.717B 0.00
Nuvalent (NUVL) United States $5.463B 0.00
Axsome Therapeutics (AXSM) United States $5.410B 0.00
Zealand Pharma (ZLDPF) Denmark $5.173B 0.00
Alkermes (ALKS) Ireland $5.135B 13.78
ADMA Biologics Inc (ADMA) United States $4.982B 37.27
Vaxcyte (PCVX) United States $4.799B 0.00
Akero Therapeutics (AKRO) United States $4.361B 0.00
Rhythm Pharmaceuticals (RYTM) United States $4.245B 0.00
Zai Lab (ZLAB) China $4.178B 0.00
PTC Therapeutics (PTCT) United States $4.097B 7.13
Cytokinetics (CYTK) United States $3.957B 0.00
Avidity Biosciences (RNA) United States $3.936B 0.00
Krystal Biotech (KRYS) United States $3.933B 30.31
Sarepta Therapeutics (SRPT) United States $3.903B 0.00
Merus (MRUS) Netherlands $3.801B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.732B 32.79
Arcellx (ACLX) United States $3.684B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.635B 0.00
SpringWorks Therapeutics (SWTX) United States $3.523B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.502B 0.00
Protagonist Therapeutics (PTGX) United States $3.451B 74.24
Scholar Rock Holding (SRRK) United States $3.235B 0.00
Alvotech (ALVO) Luxembourg $3.205B 18.33
Metsera (MTSR) United States $3.193B 0.00
Viking Therapeutics (VKTX) United States $3.096B 0.00
Kymera Therapeutics (KYMR) United States $3.071B 0.00
ImmunityBio (IBRX) United States $3.036B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.984B 0.00
Immunovant (IMVT) United States $2.784B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.782B 0.00
Ascentage Pharma Group - (AAPG) China $2.603B 0.00
Apellis Pharmaceuticals (APLS) United States $2.437B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.413B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.331B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.288B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.213B 0.00
Vericel (VCEL) United States $2.206B 1460.67
Bavarian Nordic (BVNRY) Denmark $2.166B 11.44
Denali Therapeutics (DNLI) United States $2.128B 0.00
Ligand Pharmaceuticals (LGND) United States $2.112B 0.00
CG Oncology (CGON) United States $2.058B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.034B 13.52
Twist Bioscience (TWST) United States $1.999B 0.00
Belite Bio (BLTE) United States $1.955B 0.00
Agios Pharmaceuticals (AGIO) United States $1.949B 0.00
Certara (CERT) United States $1.909B 35.67
IDEAYA Biosciences (IDYA) United States $1.901B 0.00
NovoCure (NVCR) Jersey $1.884B 0.00
Amicus Therapeutics (FOLD) United States $1.857B 201.00
Apogee Therapeutics (APGE) United States $1.848B 0.00
Beam Therapeutics (BEAM) United States $1.827B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.812B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.811B 0.00
Disc Medicine (IRON) United States $1.781B 0.00
Biohaven (BHVN) United States $1.743B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.694B 0.00
Edgewise Therapeutics (EWTX) United States $1.605B 0.00
Adaptive Biotechnologies (ADPT) United States $1.588B 0.00
89BIO (ETNB) United States $1.543B 0.00
Liquidia Technologies (LQDA) United States $1.540B 0.00
Janux Therapeutics (JANX) United States $1.535B 0.00
Mesoblast (MESO) Australia $1.514B 0.00
GRAIL (GRAL) United States $1.440B 0.00
Vera Therapeutics (VERA) United States $1.415B 0.00
Celldex Therapeutics (CLDX) United States $1.375B 0.00
ANI Pharmaceuticals (ANIP) United States $1.369B 14.10
MannKind (MNKD) United States $1.328B 27.31
Travere Therapeutics (TVTX) United States $1.324B 0.00
BGM Group (BGM) China $1.283B 0.00
Dynavax Technologies (DVAX) United States $1.234B 73.43
Viridian Therapeutics (VRDN) United States $1.212B 0.00
Anbio Biotechnology (NNNN) Germany $1.212B 0.00
Novavax (NVAX) United States $1.200B 2.80
Pacira BioSciences (PCRX) United States $1.177B 11.20
Structure Therapeutics (GPCR) United States $1.176B 0.00
WAVE Life Sciences (WVE) Singapore $1.087B 0.00
Niagen Bioscience (NAGE) United States $1.058B 149.22
Mineralys Therapeutics (MLYS) United States $1.055B 0.00
Arcus Biosciences (RCUS) United States $1.043B 0.00
Spyre Therapeutics (SYRE) United States $1.034B 0.00
Geron (GERN) United States $1.032B 0.00
CureVac (CVAC) Germany $1.005B 4.87
CorMedix Inc (CRMD) United States $0.973B 65.23
NeoGenomics (NEO) United States $0.973B 0.00
Nurix Therapeutics (NRIX) United States $0.956B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.954B 0.00
MiMedx (MDXG) United States $0.953B 23.04
Pharvaris (PHVS) Netherlands $0.943B 0.00
UniQure (QURE) Netherlands $0.926B 0.00
Praxis Precision Medicines (PRAX) United States $0.907B 0.00
LENZ Therapeutics (LENZ) United States $0.879B 0.00
Oculis Holding AG (OCS) Switzerland $0.870B 0.00
Zymeworks (ZYME) United States $0.866B 0.00
Intellia Therapeutics (NTLA) United States $0.858B 0.00
Nuvation Bio (NUVB) United States $0.854B 0.00
Pharming Group (PHAR) Netherlands $0.813B 0.00
ArriVent BioPharma (AVBP) United States $0.807B 0.00
Immunome (IMNM) United States $0.807B 0.00
Gyre Therapeutics (GYRE) United States $0.797B 212.50
Pharming Group (PHGUF) Netherlands $0.795B 0.00
Cogent Biosciences (COGT) United States $0.786B 0.00
Replimune (REPL) United States $0.785B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.760B 0.00
Trevi Therapeutics (TRVI) United States $0.752B 0.00
Vir Biotechnology (VIR) United States $0.751B 0.00
AbCellera Biologics (ABCL) Canada $0.749B 0.00
Iovance Biotherapeutics (IOVA) United States $0.738B 0.00
Immatics (IMTX) Germany $0.729B 0.00
Sionna Therapeutics (SION) United States $0.726B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.718B 0.00
GH Research (GHRS) Ireland $0.713B 0.00
Oric Pharmaceuticals (ORIC) United States $0.701B 0.00
AnaptysBio (ANAB) United States $0.681B 0.00
Anavex Life Sciences (AVXL) United States $0.677B 0.00
Arbutus Biopharma (ABUS) United States $0.672B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Sana Biotechnology (SANA) United States $0.638B 0.00
Bicara Therapeutics (BCAX) United States $0.626B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.625B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.616B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.614B 0.00
Stoke Therapeutics (STOK) United States $0.608B 14.09
Upstream Bio (UPB) United States $0.607B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.591B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.586B 0.00
Dianthus Therapeutics (DNTH) United States $0.585B 0.00
Kura Oncology (KURA) United States $0.583B 0.00
Keros Therapeutics (KROS) United States $0.572B 0.00
Arvinas (ARVN) United States $0.572B 0.00
Maze Therapeutics (MAZE) United States $0.561B 0.00
Tyra Biosciences (TYRA) United States $0.545B 0.00
Opthea (OPT) Australia $0.525B 0.00
Castle Biosciences (CSTL) United States $0.525B 35.63
Cullinan Therapeutics (CGEM) United States $0.517B 0.00
MeiraGTx Holdings (MGTX) United States $0.508B 0.00
Zenas BioPharma (ZBIO) United States $0.499B 0.00
Fortrea Holdings (FTRE) United States $0.498B 13.75
Abivax SA (ABVX) France $0.495B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.494B 0.00
Celcuity (CELC) United States $0.489B 0.00
ATyr Pharma (ATYR) United States $0.485B 0.00
Myriad Genetics (MYGN) United States $0.478B 0.00
REGENXBIO (RGNX) United States $0.478B 0.00
Rapport Therapeutics (RAPP) United States $0.464B 0.00
Erasca (ERAS) United States $0.462B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.459B 0.00
Tectonic Therapeutic (TECX) United States $0.457B 0.00
Tango Therapeutics (TNGX) United States $0.451B 0.00
Cytek Biosciences (CTKB) United States $0.451B 0.00
Septerna (SEPN) United States $0.450B 0.00
Precigen (PGEN) United States $0.443B 0.00
PureTech Health (PRTC) United States $0.440B 0.00
Sage Therapeutics (SAGE) United States $0.426B 0.00
Eton Pharmaceuticals (ETON) United States $0.425B 0.00
Benitec Biopharma (BNTC) United States $0.424B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.421B 0.00
Kamada (KMDA) Israel $0.401B 24.03
Northwest Biotherapeutics (NWBO) United States $0.399B 0.00
Humacyte (HUMA) United States $0.397B 0.00
Fulcrum Therapeutics (FULC) United States $0.384B 0.00
ITeos Therapeutics (ITOS) United States $0.384B 0.00
MBX Biosciences (MBX) United States $0.380B 0.00
Absci (ABSI) United States $0.379B 0.00
Checkpoint Therapeutics (CKPT) United States $0.371B 0.00
Rezolute (RZLT) United States $0.369B 0.00
Vigil Neuroscience (VIGL) United States $0.368B 0.00
Solid Biosciences (SLDB) United States $0.358B 0.00
Compass Therapeutics (CMPX) United States $0.355B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.354B 0.00
Emergent Biosolutions (EBS) United States $0.352B 0.00
Inventiva S.A (IVA) France $0.346B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.340B 0.00
Verastem (VSTM) United States $0.336B 0.00
Abeona Therapeutics (ABEO) United States $0.335B 0.00
Astria Therapeutics (ATXS) United States $0.327B 0.00
Terns Pharmaceuticals (TERN) United States $0.324B 0.00
Urogen Pharma (URGN) United States $0.324B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.322B 0.00
Cidara Therapeutics (CDTX) United States $0.318B 0.00
Ocugen (OCGN) United States $0.318B 0.00
Alpha Teknova (TKNO) United States $0.317B 0.00
Aura Biosciences (AURA) United States $0.316B 0.00
Allogene Therapeutics (ALLO) United States $0.308B 0.00
Entrada Therapeutics (TRDA) United States $0.308B 10.01
Monte Rosa Therapeutics (GLUE) United States $0.303B 61.50
XOMA Royalty (XOMA) United States $0.303B 0.00
Gossamer Bio (GOSS) United States $0.302B 0.00
Olema Pharmaceuticals (OLMA) United States $0.300B 0.00
Palvella Therapeutics (PVLA) United States $0.294B 0.00
Candel Therapeutics (CADL) United States $0.294B 0.00
Annexon (ANNX) United States $0.284B 0.00
Neurogene (NGNE) United States $0.284B 0.00
Prothena (PRTA) Ireland $0.283B 0.00
Cartesian Therapeutics (RNAC) United States $0.282B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.275B 0.00
Atea Pharmaceuticals (AVIR) United States $0.275B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.271B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.269B 0.00
Prima BioMed (IMMP) Australia $0.269B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Inozyme Pharma (INZY) United States $0.257B 0.00
Cardiff Oncology (CRDF) United States $0.257B 0.00
Foghorn Therapeutics (FHTX) United States $0.256B 0.00
Amarin (AMRN) Ireland $0.255B 0.00
Aardvark Therapeutics (AARD) United States $0.253B 0.00
Tvardi Therapeutics (TVRD) United States $0.252B 0.00
Lifecore Biomedical (LFCR) United States $0.251B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.243B 0.00
BioStem Technologies (BSEM) $0.239B 9.73
Third Harmonic Bio (THRD) United States $0.239B 0.00
DBV Technologies S.A (DBVT) France $0.238B 0.00
MaxCyte (MXCT) United States $0.232B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.230B 0.00
Instil Bio (TIL) United States $0.230B 0.00
ACELYRIN, INC (SLRN) United States $0.229B 0.00
I-Mab (IMAB) United States $0.229B 0.00
Adherex Technologies (FENC) United States $0.228B 0.00
ScPharmaceuticals (SCPH) United States $0.224B 0.00
Design Therapeutics (DSGN) United States $0.222B 0.00
Prime Medicine (PRME) United States $0.219B 0.00
Kodiak Sciences (KOD) United States $0.219B 0.00
CARGO Therapeutics (CRGX) United States $0.214B 0.00
Adocia (ADOCY) France $0.213B 0.00
CytomX Therapeutics (CTMX) United States $0.212B 5.49
Monopar Therapeutics (MNPR) United States $0.212B 0.00
AC Immune (ACIU) Switzerland $0.211B 0.00
GENFIT S.A (GNFT) France $0.210B 0.00
Inhibrx Biosciences (INBX) United States $0.208B 0.12
Semper Paratus Acquisition (TVGN) United States $0.202B 0.00
Codexis (CDXS) United States $0.197B 0.00
Bright Minds Biosciences (DRUG) United States $0.196B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.193B 0.00
Innate Pharma S.A (IPHA) France $0.192B 0.00
Voyager Therapeutics (VYGR) United States $0.185B 0.00
Nuvectis Pharma (NVCT) United States $0.185B 0.00
Ventyx Biosciences (VTYX) United States $0.182B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.179B 0.00
Puma Biotechnology (PBYI) United States $0.179B 4.68
Neumora Therapeutics (NMRA) United States $0.176B 0.00
INmune Bio (INMB) United States $0.176B 0.00
DiaMedica Therapeutics (DMAC) United States $0.175B 0.00
Fate Therapeutics (FATE) United States $0.174B 0.00
Actuate Therapeutics (ACTU) United States $0.171B 0.00
EnGene Holdings (ENGN) Canada $0.171B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.166B 0.00
Anika Therapeutics (ANIK) United States $0.165B 0.00
23andMe Holding (MEHCQ) United States $0.164B 0.00
Sagimet Biosciences (SGMT) United States $0.164B 0.00
Alumis (ALMS) United States $0.162B 0.00
Editas Medicine (EDIT) United States $0.162B 0.00
Rapt Therapeutics (RAPT) United States $0.159B 0.00
Molecular Partners AG (MOLN) Switzerland $0.157B 0.00
Galena Biopharma (SLS) United States $0.157B 0.00
Spero Therapeutics (SPRO) United States $0.154B 0.00
BioAge Labs (BIOA) United States $0.154B 0.00
Agenus (AGEN) United States $0.152B 0.00
Compugen (CGEN) Israel $0.152B 0.00
Kyverna Therapeutics (KYTX) United States $0.149B 0.00
Alpha Cognition (ACOG) Canada $0.147B 0.00
Alector (ALEC) United States $0.144B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.142B 0.00
Black Diamond Therapeutics (BDTX) United States $0.141B 41.33
Nkarta (NKTX) United States $0.133B 0.00
Seer (SEER) United States $0.130B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.128B 0.00
Elicio Therapeutics (ELTX) United States $0.128B 0.00
Greenwich LifeSciences (GLSI) United States $0.126B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.126B 0.00
TuHURA Biosciences (HURA) United States $0.126B 0.00
Cabaletta Bio (CABA) United States $0.120B 0.00
Theratechnologies (THTX) Canada $0.120B 0.00
C4 Therapeutics (CCCC) United States $0.119B 0.00
Sangamo Therapeutics (SGMO) United States $0.119B 0.00
Caribou Biosciences (CRBU) United States $0.118B 0.00
EXoZymes (EXOZ) United States $0.117B 0.00
Invivyd (IVVD) United States $0.116B 0.00
Contineum Therapeutics (CTNM) United States $0.116B 0.00
BioHarvest Sciences (BHST) Canada $0.115B 0.00
Tenaya Therapeutics (TNYA) United States $0.111B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.110B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.107B 0.00
HilleVax (HLVX) United States $0.102B 0.00
Genelux (GNLX) United States $0.102B 0.00
IO Biotech (IOBT) Denmark $0.102B 0.00
TScan Therapeutics (TCRX) United States $0.100B 0.00
Coherus BioSciences (CHRS) United States $0.099B 0.00
Biomea Fusion (BMEA) United States $0.099B 0.00
Coya Therapeutics (COYA) United States $0.098B 0.00
Pliant Therapeutics (PLRX) United States $0.098B 0.00
Nautilus Biotechnology (NAUT) United States $0.097B 0.00
Entera Bio (ENTX) Israel $0.096B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.094B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.094B 0.00
Whitehawk Therapeutics (WHWK) United States $0.092B 0.00
Climb Bio (CLYM) United States $0.091B 0.00
Adagene (ADAG) China $0.090B 0.00
XBiotech (XBIT) United States $0.090B 0.00
Jasper Therapeutics (JSPR) United States $0.089B 0.00
BeyondSpring (BYSI) United States $0.089B 0.00
Citius Oncology (CTOR) United States $0.088B 0.00
Zura Bio (ZURA) United States $0.085B 0.00
Immunic (IMUX) United States $0.083B 0.00
Inovio Pharmaceuticals (INO) United States $0.081B 0.00
Senti Biosciences (SNTI) United States $0.081B 0.00
Cellectis S.A (CLLS) France $0.079B 0.00
Forte Biosciences (FBRX) United States $0.079B 0.00
PDS Biotechnology (PDSB) United States $0.078B 0.00
Immuneering (IMRX) United States $0.078B 0.00
Elutia (ELUT) United States $0.078B 0.00
IGM Biosciences (IGMS) United States $0.077B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.077B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.075B 0.00
TELA Bio (TELA) United States $0.074B 0.00
Genenta Science S.p.A (GNTA) Italy $0.073B 0.00
Skye Bioscience (SKYE) United States $0.072B 0.00
Seres Therapeutics (MCRB) United States $0.071B 0.00
OKYO Pharma (OKYO) $0.071B 0.00
Ikena Oncology (IKNA) United States $0.071B 0.00
Sutro Biopharma (STRO) United States $0.070B 0.00
MediciNova (MNOV) United States $0.070B 0.00
Alto Neuroscience (ANRO) United States $0.069B 0.00
VistaGen Therapeutics (VTGN) United States $0.068B 0.00
CervoMed (CRVO) United States $0.067B 0.00
ZIVO Bioscience (ZIVO) United States $0.066B 0.00
Immix Biopharma (IMMX) United States $0.065B 0.00
Oncobiologics (OTLK) United States $0.064B 0.00
Adicet Bio (ACET) United States $0.064B 0.00
Werewolf Therapeutics (HOWL) United States $0.063B 0.00
Repare Therapeutics (RPTX) Canada $0.063B 0.00
Fortress Biotech (FBIO) United States $0.063B 0.00
Opus Genetics (IRD) United States $0.063B 0.00
Adverum Biotechnologies (ADVM) United States $0.062B 0.00
Renovaro (RENB) United States $0.062B 0.00
Exicure (XCUR) United States $0.061B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Annovis Bio (ANVS) United States $0.060B 0.00
Adlai Nortye (ANL) Cayman Islands $0.059B 0.00
Clearside Biomedical (CLSD) United States $0.059B 0.00
Precision BioSciences (DTIL) United States $0.059B 0.00
Kalaris Therapeutics (KLRS) United States $0.057B 0.00
InflaRx (IFRX) Germany $0.057B 0.00
Shattuck Labs (STTK) United States $0.057B 0.00
Applied Therapeutics (APLT) United States $0.056B 0.00
Akoya Biosciences (AKYA) United States $0.056B 0.00
Atara Biotherapeutics (ATRA) United States $0.055B 0.00
Quince Therapeutics (QNCX) United States $0.053B 0.00
Kronos Bio (KRON) United States $0.053B 0.00
VTv Therapeutics (VTVT) United States $0.053B 0.00
Artiva Biotherapeutics (ARTV) United States $0.051B 0.00
RenovoRx (RNXT) United States $0.050B 0.00
PepGen (PEPG) United States $0.050B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
Mersana Therapeutics (MRSN) United States $0.049B 0.00
Cue Biopharma (CUE) United States $0.048B 0.00
Celularity (CELU) United States $0.047B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.045B 0.00
Aligos Therapeutics (ALGS) United States $0.044B 0.00
Rein Therapeutics (RNTX) United States $0.044B 0.00
Connect Biopharma Holdings (CNTB) United States $0.043B 0.00
Scilex Holding (SCLX) United States $0.043B 0.00
Alterity Therapeutics - (ATHE) Australia $0.043B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.042B 0.00
Quantum Biopharma (QNTM) Canada $0.041B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.040B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.040B 0.00
Medicus Pharma (MDCX) United States $0.039B 0.00
OnKure Therapeutics (OKUR) United States $0.039B 0.00
Oncolytics Biotech (ONCY) Canada $0.039B 0.00
Clene (CLNN) United States $0.038B 0.00
CAMP4 Therapeutics (CAMP) United States $0.037B 0.00
Lantern Pharma (LTRN) United States $0.036B 0.00
Radiopharm Theranostics - (RADX) Australia $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
FibroBiologics (FBLG) United States $0.036B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.036B 0.00
Estrella Immunopharma (ESLA) United States $0.036B 0.00
Pluri (PLUR) Israel $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.034B 0.00
Rani Therapeutics Holdings (RANI) United States $0.033B 0.00
Kezar Life Sciences (KZR) United States $0.033B 0.00
Grace Therapeutics (GRCE) Canada $0.032B 0.00
ALX Oncology Holdings (ALXO) United States $0.031B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.031B 0.00
Allakos (ALLK) United States $0.030B 0.00
BioAtla (BCAB) United States $0.030B 0.00
Dyadic (DYAI) United States $0.030B 0.00
Cadrenal Therapeutics (CVKD) United States $0.030B 0.00
Passage Bio (PASG) United States $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Vor Biopharma (VOR) $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
ABVC BioPharma (ABVC) United States $0.028B 0.00
Generation Bio (GBIO) United States $0.027B 0.00
KALA BIO (KALA) United States $0.027B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.026B 0.00
Curis (CRIS) United States $0.026B 0.00
CalciMedica (CALC) United States $0.025B 0.00
Chemomab Therapeutics (CMMB) Israel $0.025B 0.00
Boundless Bio (BOLD) United States $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
X4 Pharmaceuticals (XFOR) United States $0.024B 0.00
Ovid Therapeutics (OVID) United States $0.024B 0.00
Imunon (IMNN) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
Q32 Bio (QTTB) United States $0.022B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.022B 0.00
Femasys (FEMY) United States $0.020B 0.00
Advanced Biomed (ADVB) United States $0.020B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.020B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.020B 0.00
Cingulate (CING) United States $0.019B 0.00
Longeveron (LGVN) United States $0.019B 0.00
Cognition Therapeutics (CGTX) United States $0.019B 0.00
HOOKIPA Pharma (HOOK) United States $0.019B 0.00
GeoVax Labs (GOVX) United States $0.018B 0.00
Lexaria Bioscience (LEXX) Canada $0.018B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
Leap Therapeutics (LPTX) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.016B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
Gelteq (GELS) Australia $0.016B 0.00
Hoth Therapeutics (HOTH) United States $0.016B 0.00
Rallybio (RLYB) United States $0.016B 0.00
IBio (IBIO) United States $0.015B 0.00
Abpro Holdings (ABP) United States $0.015B 0.00
NextCure (NXTC) United States $0.015B 0.00
Synlogic (SYBX) United States $0.015B 0.00
MetaVia (MTVA) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Biorestorative Therapies (BRTX) United States $0.014B 0.00
Equillium (EQ) United States $0.014B 0.00
Allarity Therapeutics (ALLR) United States $0.013B 0.00
Aytu BioPharma (AYTU) United States $0.013B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.013B 0.00
Athira Pharma (ATHA) United States $0.013B 0.00
BRIACELL THERAP (BCTX) Canada $0.013B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
Eyenovia (EYEN) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
UNITY Biotechnology (UBX) United States $0.012B 0.00
BioXcel Therapeutics (BTAI) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
BioCardia (BCDA) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
IN8bio (INAB) United States $0.009B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
Intensity Therapeutics (INTS) United States $0.009B 0.00
Sensei Biotherapeutics (SNSE) United States $0.009B 0.00
GENPREX (GNPX) United States $0.009B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.008B 0.00
HCW Biologics (HCWB) United States $0.008B 0.00
Portage Biotech (PRTG) $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
GT Biopharma (GTBP) United States $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.008B 0.00
Apollomics (APLM) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
180 Life Sciences (ATNF) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Mustang Bio (MBIO) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Novogen (KZIA) Australia $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Capstone Therapeutics (CAPS) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00